Number of the records: 1  

Altered expression of p53 and MDM2 proteins in hematological malignancies

  1. TitleAltered expression of p53 and MDM2 proteins in hematological malignancies
    Author Koníková Edita SAVEXONK - Ústav experimentálnej onkológie SAV
    Co-authors Kusenda Ján 1961- SAVEXONK - Ústav experimentálnej onkológie SAV    RID    ORCID

    Source document Neoplasma. Vol. 50, no. 1 (2003), p. 31-40. - Bratislava : Ústav experimentálnej onkológie, Biomedicínske centrum SAV, 1954-
    Languageeng - English
    CountrySK - Slovak Republic
    Document kindrozpis článkov z periodík (rbx)
    CitationsKOJIMA, Kensuke - KONOPLEVA, Marina - MCQUEEN, Teresa - O'BRIEN, Susan - PLUNKETT, William - ANDREEFF, Michael. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. In BLOOD. ISSN 0006-4971, 2006, vol. 108, no. 3, pp. 993.
    MCMILLIN, Douglas W. - DELMORE, Jake - NEGRI, Joseph M. - VANNEMAN, Matthew - KOYAMA, Shohei - SCHLOSSMAN, Robert L. - MUNSHI, Nikhil C. - LAUBACH, Jacob - RICHARDSON, Paul G. - DRANOFF, Glenn - ANDERSON, Kenneth C. - MITSIADES, Constantine S. Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function. In BLOOD. ISSN 0006-4971, 2012, vol. 119, no. 15, pp. E131.
    PHANG, Beng Hooi - LINN, Yeh Ching - LI, Huihua - SABAPATHY, Kanaga. MDM2 SNP309 G allele decreases risk but does not affect onset age or survival of Chinese leukaemia patients. In EUROPEAN JOURNAL OF CANCER. ISSN 0959-8049, 2008, vol. 44, no. 5, pp. 760.
    KOFLER, D. M. - MAYR, C. - WENDTNER, C.M. Current status of immunotherapy in B cell malignancies. In CURRENT DRUG TARGETS. ISSN 1389-4501, 2006, vol. 7, no. 10, pp. 1371.
    ANTOSZ, Halina - PATERSKI, Artur - MARZEC-KOTARSKA, Barbara - SAJEWICZ, Joanna - DMOSZYNSKA, Anna. Alterations in TP53, cyclin D2, c-Myc, p21(WAF1/CIP1) and p27(KIP1) expression associated with progression in B-CLL. In FOLIA HISTOCHEMICA ET CYTOBIOLOGICA. ISSN 0239-8508, 2010, vol. 48, no. 4, pp. 534.
    MICHAEL, B - NAIR, A - LAIRMORE, MD. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. In FRONTIERS IN BIOSCIENCE. ISSN 1093-9946, 2004, vol. 9, no., pp. 2556.
    PUIGGROS, Anna - BLANCO, Gonzalo - ESPINET, Blanca. Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go. In BIOMED RESEARCH INTERNATIONAL. ISSN 2314-6133, 2014, vol., no., pp.
    MARTEIJN, J. A. F. - JANSEN, J. H. - VAN DER REIJDEN, B. A. Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets. In LEUKEMIA. ISSN 0887-6924, 2006, vol. 20, no. 9, pp. 1511.
    HENDY, Olfat M. - ELGHANNAM, Doaa M. - EL-SHARNOUBY, Jehan A. - GODA, Enas F. - EL-ASHRY, Rasha - AL-TONBARY, Youssef. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia. In HEMATOLOGY. ISSN 1024-5332, 2009, vol. 14, no. 6, pp. 335.
    RAYBURN, E - ZHANG, RW - HE, J - WANG, H. MDM2 and human malignancies: Expression, clinical pathology, prognostic markers, and implications for chemotherapy. In CURRENT CANCER DRUG TARGETS. ISSN 1568-0096, 2005, vol. 5, no. 1, pp. 27.
    DE VIRON, Emeline - MICHAUX, Lucienne - PUT, Natalie - BONTEMPS, Francoise - VAN DEN NESTE, Eric. Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia. In LEUKEMIA & LYMPHOMA. ISSN 1042-8194, 2012, vol. 53, no. 8, pp. 1445.
    BOSMAN, Matthieu Cornelis Johannes - SCHURINGA, Jan Jacob - VELLENGA, Edo. Constitutive NF-kappa B activation in AML: Causes and treatment strategies. In CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. ISSN 1040-8428, 2016, vol. 98, no., pp. 35.
    O'BRATE, A - GIANNAKAKOU, P. The importance of p53 location: nuclear or cytoplasmic zip code? In DRUG RESISTANCE UPDATES. ISSN 1368-7646, 2003, vol. 6, no. 6, pp. 313.
    SECCHIERO, Paola - DI IASIO, Maria Grazia - GONELLI, Arianna - ZAULI, Giorgio. The MDM2 inhibitor nutlins as an innovative therapeutic tool for the treatment of haematological malignancies. In CURRENT PHARMACEUTICAL DESIGN. ISSN 1381-6128, 2008, vol. 14, no. 21, pp. 2100.
    WU, H - HAYASHI, T - INOUE, M. Immunohistochemical expression of Mdm2 and p53 in canine cutaneous mast cell tumours. In JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE. ISSN 0931-184X, 2006, vol. 53, no. 2, pp. 65.
    WANG, Xiaohong - LI, Shulin. Protein mislocalization: Mechanisms, functions and clinical applications in cancer. In BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. ISSN 0304-419X, 2014, vol. 1846, no. 1, pp. 13.
    MUTTRAY, AF - COX, RL - ST-JEAN, S - VAN POPPELEN, P - REINISCH, CL - BALDWIN, SA. Identification and phylogenetic comparison of p53 in two distinct mussel species (Mytilus). In COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY. ISSN 1532-0456, 2005, vol. 140, no. 2, pp. 237.
    ISIN, Mustafa - YENEREL, Mustafa - AKTAN, Melih - BUYRU, Nur - DALAY, Nejat. Analysis of p53 tumor suppressor pathway genes in chronic lymphocytic leukemia. In DNA and Cell Biology. ISSN 10445498, 2012-05-01, 31, 5, pp. 777-782.
    ABRAMOWITZ, Julia - NEUMAN, Tzahi - PERLMAN, Riki - BEN-YEHUDA, Dina. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia. In BMC MEDICAL GENOMICS. ISSN 1755-8794, 2017, vol. 10, no., pp.
    MARCONDES, Natalia - FERNANDES, Flavo - FAULHABER, Gustavo. Ki-67 expression in mature B-cell neoplasms: a flow cytometry study. In REVISTA DA ASSOCIACAO MEDICA BRASILEIRA. ISSN 0104-4230, 2018, vol. 64, no. 6, pp. 525-529.
    ALVES-SILVA, Juliana Carvalho - DE CARVALHO, Juliana Lott - RABELLO, Doralina Amaral - TAVARES SEREJO, Teresa Raquel - REGO, Eduardo Magalhaes - ROCHA NEVES, Francisco Assis - LUCENA-ARAUJO, Antonio Roberto - PITTELLA-SILVA, Fabio - SALDANHA-ARAUJO, Felipe. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death. In INVESTIGATIONAL NEW DRUGS. ISSN 0167-6997, 2018, vol. 36, no. 5, pp. 955-960.
    CIARDULLO, Carmela - APTULLAHOGLU, Erhan - WOODHOUSE, Laura - LIN, Wei-Yu - WALLIS, Jonathan P. - MARR, Helen - MARSHALL, Scott - BOWN, Nick - WILLMORE, Elaine - LUNEC, John. Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells. In HAEMATOLOGICA. ISSN 0390-6078, 2019, vol. 104, no. 12, pp. 2429-2442.
    CategoryADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2003
    Registered inWOS
    Registered inSCOPUS
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    200320020.679
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.